$0.8976
0.02252.57%
Last update: Oct 28, 6:15 PM
Cardiff Oncology Inc (CRDF) Stock Price, Quote, News & History
CRDFNASDAQ
Dow gains over 150 points, NASDAQ and S&P 500 also up. Consumer discretionary shares jump 1.2%, energy stocks fall 0.5%. Producer price index falls below...
You can purchase shares of Cardiff Oncology (NASDAQ:CRDF) through any online brokerage.
Other companies in Cardiff Oncology’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Cardiff Oncology has a consensus price target of $8.93.
The stock price for Cardiff Oncology (NASDAQ: CRDF) is $0.8703 last updated October 28, 2026 at 6:15 PM EDT.
There are no upcoming dividends for Cardiff Oncology.
Cardiff Oncology does not have any upcoming earnings scheduled.
There is no upcoming split for Cardiff Oncology.
Cardiff Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Cardiff Oncology Inc is a clinical-stage biotechnology company advancing cancer treatments focused on PLK1 inhibition, a validated oncology target with practice-changing potential. Its main asset, onvansertib, is a specific, oral PLK1 inhibitor...
